The battle against fungi: lessons in antifungal stewardship from COVID 19 times

Journal Information

Full Title: Int J Antimicrob Agents

Abbreviation: Int J Antimicrob Agents

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Anti-Infective Agents

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declarations Funding: No funding was received for the conception of this manuscript Competing Interests: All authors declare potential conflict of interest regarding the manuscript as noted below: Souha S. Kanj Pfizer, MSD, Menarini, Basilia, Gilead personal funds Sara F. Haddad NO conflict of interest Jacques F. Meis NO conflict of interest Paul E. Verweij F2G, Gilead, Pfizer and Mundipharma funds all paid to institution Andreas Voss NO conflict of interest Riina Rautemaa-Richardson Pfizer, Mundipharma, Gilead personal funds Gabriel Levy-Hara Advisory board of Biomerieux / Roche Diagnostics Latin America Anuradha Chowdhary NO conflict of interest Abdul Ghafur NO conflict of interest Roger Brüggemann NO conflict of interest Abhijit M. Bal Pfizer, Astellas, Gilead, Menarini, Tillots Jeroen Schouten NO conflict of interest Ethical Approval: Not required. Sequence Information: Not applicable. Competing Interests: All authors declare potential conflict of interest regarding the manuscript as noted below:"

Evidence found in paper:

"Funding: No funding was received for the conception of this manuscript"

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025